442 related articles for article (PubMed ID: 26179950)
21. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and clinical significance of lymph node metastases near the recurrent laryngeal nerve from thoracic esophageal carcinoma.
Ye K; Xu JH; Sun YF; Lin JA; Zheng ZG
Genet Mol Res; 2014 Aug; 13(3):6411-9. PubMed ID: 25158259
[TBL] [Abstract][Full Text] [Related]
23. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
[TBL] [Abstract][Full Text] [Related]
24. Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.
Matsuda S; Takeuchi H; Kawakubo H; Ando N; Kitagawa Y
Ann Thorac Cardiovasc Surg; 2016 Oct; 22(5):275-283. PubMed ID: 27384595
[TBL] [Abstract][Full Text] [Related]
25. [Long-term outcome of neoadjuvant radiochemotherapy followed by surgery for esophageal cancer: a single institution retrospective study of 102 patients].
Ruffier-Loubière A; Janoray G; Chapet S; de Calan L; Dumont P; Dorval É; Orain I; Calais G
Cancer Radiother; 2015 Aug; 19(5):322-30. PubMed ID: 26215366
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer.
Bollschweiler E; Hölscher AH; Metzger R; Besch S; Mönig SP; Baldus SE; Drebber U
Ann Thorac Surg; 2011 Dec; 92(6):2020-7. PubMed ID: 22115212
[TBL] [Abstract][Full Text] [Related]
27. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
29. [Clinical value of para-recurrent laryngeal nerve lymphadenectomy for middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu S
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):867-70. PubMed ID: 26404679
[TBL] [Abstract][Full Text] [Related]
30. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
31. Which is the optimal response criteria for evaluating preoperative treatment in esophageal cancer: RECIST or histology?
Kurokawa Y; Shibata T; Ando N; Seki S; Mukaida H; Fukuda H
Ann Surg Oncol; 2013 Sep; 20(9):3009-14. PubMed ID: 23504143
[TBL] [Abstract][Full Text] [Related]
32. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
33. Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Mori M; Doki Y
Oncol Rep; 2010 May; 23(5):1331-7. PubMed ID: 20372848
[TBL] [Abstract][Full Text] [Related]
34. Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma.
Hiraki Y; Kimura Y; Imano M; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Makino T; Motoori M; Yamasaki M; Miyata H; Satou T; Satoh T; Furukawa H; Yano M; Doki Y; Yasuda T
Surg Today; 2021 Jan; 51(1):118-126. PubMed ID: 32596796
[TBL] [Abstract][Full Text] [Related]
35. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
[TBL] [Abstract][Full Text] [Related]
36. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.
Lin Z; Chen W; Chen Y; Peng X; Zhu K; Lin Y; Lin Q; Hu Z
Oncotarget; 2016 Nov; 7(46):76261-76273. PubMed ID: 27788489
[TBL] [Abstract][Full Text] [Related]
37. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
[TBL] [Abstract][Full Text] [Related]
38. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
39. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
40. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
